ArticleSignal transduction and targeted therapy

Targeting the CXCR4/CXCL12 axis with the peptide antagonist E5 to inhibit breast tumor progression.

Hua Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.